Results 201 to 210 of about 464,004 (267)
Early Development of Sildenafil for Pulmonary Hypertension: A Retrospective Account. [PDF]
Butrous G.
europepmc +1 more source
FREQUENCY OF PULMONARY HYPERTENSION IN CASES OF INTERSTITIAL LUNG DISEASE: CROSS-SECTIONAL STUDY
Zahir Shah +4 more
openalex +2 more sources
Cilostazol Therapy Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat Model
Li‐Teh Chang +7 more
openalex +2 more sources
Disproportionality analyses suggested a cardiovascular risk signal for romosozumab, while statistically significant associations were not found in the real‐world database studies. Therefore, a larger comparative study was necessary to examine this signal.
Hotaka Maruyama +5 more
wiley +1 more source
Plasma interferon predicts pulmonary hypertension severity and outcome. [PDF]
Liang Z +7 more
europepmc +1 more source
ABSTRACT Objective Binge eating disorder (BED) is maintained by increased food‐related incentive salience, which is reflected by an attentional bias for food. Oxytocin acutely attenuates this bias in patients with anorexia nervosa and reduces food intake in males with normal or increased body weight.
Julia Nannt +6 more
wiley +1 more source
Northern Pulmonary Hypertension: Personal Experience and Brief History. [PDF]
Chernyaev AL.
europepmc +1 more source
Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang +7 more
wiley +1 more source
Will Stub1 Be the Next Target for Pulmonary Hypertension Therapy Development? [PDF]
Shen Y.
europepmc +1 more source
Association of COPD with adverse outcomes in heart failure patients with preserved ejection fraction
Abstract We performed a systematic review and meta‐analysis to detect the impact of chronic obstructive pulmonary disease (COPD) on the prognosis of heart failure patients with preserved ejection fraction (HFpEF). We systematically screened eligible literature from three electronic databases, PubMed, EMBASE and Cochrane Library, up to April 2023.
Shuo Xu +3 more
wiley +1 more source

